The U.S. has shifted to a campaign of economic warfare, after a dozen waves of airstrikes in July failed to force Tehran to ...
Rare disease drug development is getting a boost from new funding models and a growing group of smaller biotech buyers.
Salesforce's stock had its second-best day on record following earnings, as Wall Street shows renewed confidence in CEO Marc ...
Marvell Technology shares fell 8% in premarket trading despite a second-quarter revenue beat, as its fiscal 2028 outlook ...
1h
Judge again blocks Trump mail ballot executive order in ruling that’s likely to be swiftly appealed
A federal judge on Thursday halted — at least for now — attempts to implement President Donald Trump's executive order ...
Gamers got their first look at gameplay of the latest Grand Theft Auto title in a release on Netflix, with Christopher Dring, ...
Maxime Darmet, Senior Economist at Allianz Trade, discusses his outlook for the French presidential elections, and explains ...
CNBC's Kai Nicol-Schwarz discusses how Nvidia is bolstering support for Chinese open AI models, even as it warns of potential ...
Markets await the much-anticipated speech from Federal Reserve Chairman Kevin Warsh amid the recent volatility in bond yields ...
The Zephirin Group analyst Lenny Zephirin discusses Manycore’s first-half results, including slowing domestic growth, ...
Kamran Bokhari, Strategic Forecaster and Senior Resident Fellow at the Middle East Policy Council, says a possible strategic ...
4h
Warsh unlikely to give 'end goal' in rate policy at Jackson Hole, but could signal methodology: OCBC
Chez Anbu, Head of Wealth Advisory at OCBC, talks expectations ahead of Fed Chairman Kevin Warsh's Jackson Hole speech - ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results